Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKritsada Pruksaphonen_US
dc.contributor.authorAkarin Intaramaten_US
dc.contributor.authorKavi Ratanabanangkoonen_US
dc.contributor.authorJoshua D. Nosanchuken_US
dc.contributor.authorNongnuch Vanittanakomen_US
dc.contributor.authorSirida Youngchimen_US
dc.description.abstract© 2019 Elsevier Inc. The pathogenic fungus Talaromyces (formerly Penicillium) marneffei is a thermally dimorphic fungus that can cause disseminated infection in patients with secondary immunodeficiency syndrome, in particular in the setting of advanced HIV infection. The areas of highest incidence are in Southeast Asia, Southern China, and Indian subcontinents. Talaromycosis (formerly penicilliosis) is identified as an AIDS-defining illness, and it has recently been recognized in non–HIV-associated patients with impaired cellular-mediated immunity. Microbiological culture is the gold standard method for the diagnosis of T. marneffei infection and usually requires up to 2–4 weeks for detectable growth to occur, which may result in a delay of appropriate treatment. Immunodiagnosis has become an alternative method for confirming talaromycosis. This article reviews various immunological tests for the diagnosis of talaromycosis, including a proposed novel rapid point-of-care assay using a new T. marneffei yeast phase-specific monoclonal antibody.en_US
dc.titleDiagnostic laboratory immunology for talaromycosis (penicilliosis): review from the bench-top techniques to the point-of-care testingen_US
article.title.sourcetitleDiagnostic Microbiology and Infectious Diseaseen_US
article.volume96en_US Research Instituteen_US Universityen_US Einstein College of Medicine of Yeshiva Universityen_US Mai Universityen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.

Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.